[7] Treatment with Ozempic may lead to reductions in common symptoms associated with PCOS, such as obesity, increased hair growth, menstrual irregularities, and reduced ovarian function
What stood out: CagriSema achieved 23.0% weight loss at 84 weeks (efficacy estimand) Tirzepatide achieved 25.5% On the treatment-regimen estimand, weight loss was 20.2% vs 23.6% Primary endpoint not met: CagriSema did not demonstrate non-inferiority vs tirzepatide on weight loss at 84 weeks Why this matters This is a reminder that in obesity pharmacotherapy, very effective and best-in-class are not the same conversation
BPC-157 is a gastric-derived peptide with strong research backing in tendon, ligament, and gut healing models
For mood enhancing properties, studies have shown that Taurine and caffeine have proven to be very effective
The role of vitamins and minerals in hair loss: a review
In the case of semaglutides and Emsculpt, the combination of medical advancements can be paired with cutting-edge technology to aid in healthy weight loss, maintaining muscle tone, and offering a more comprehensive benefit than the medications alone